This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v1.0.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Active as of 2024-12-06 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="inca-osiris"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem inca-osiris</b></p><a name="inca-osiris"> </a><a name="hcinca-osiris"> </a><a name="inca-osiris-en-US"> </a><p>This case-sensitive code system <code>https://twcore.mohw.gov.tw/ig/pas/CodeSystem/inca-osiris</code> defines the following code:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">O55-2<a name="inca-osiris-O55-2"> </a></td><td>Delins</td></tr></table></div>
</text>
<url value="https://twcore.mohw.gov.tw/ig/pas/CodeSystem/inca-osiris"/>
<version value="1.0.1"/>
<name value="INCaOsiris"/>
<title value="INCa-健保事前審查-基因突變類型"/>
<status value="active"/>
<experimental value="false"/>
<date value="2024-12-06"/>
<publisher value="衛生福利部中央健康保險署"/>
<contact>
<name value="衛生福利部中央健康保險署"/>
<telecom>
<system value="url"/>
<value value="https://www.nhi.gov.tw"/>
</telecom>
</contact>
<description
value="INCa-健保事前審查-基因突變類型,資料所屬單位:Institut National du Cancer (INCa),參照至:https://github.com/InstitutNationalduCancer/OSIRIS。"/>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="1"/>
<concept>
<code value="O55-2"/>
<display value="Delins"/>
</concept>
</CodeSystem>